| Primary |
| Product Used For Unknown Indication |
30.6% |
| Pain |
21.4% |
| Drug Use For Unknown Indication |
7.1% |
| Hypertension |
6.1% |
| Back Pain |
5.1% |
| Thrombosis Prophylaxis |
4.1% |
| Arthralgia |
3.1% |
| Gastroenteritis |
3.1% |
| Mineral Supplementation |
3.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.1% |
| Arrhythmia |
2.0% |
| Clostridial Infection |
2.0% |
| Hyperthyroidism |
2.0% |
| Anaemia |
1.0% |
| Benign Prostatic Hyperplasia |
1.0% |
| Constipation |
1.0% |
| Diverticulum |
1.0% |
| Dizziness |
1.0% |
| Flatulence |
1.0% |
| Gastric Ph Decreased |
1.0% |
|
| Vomiting |
12.5% |
| Nausea |
8.3% |
| Respiratory Depression |
8.3% |
| Angioedema |
4.2% |
| Application Site Pruritus |
4.2% |
| Blood Pressure Decreased |
4.2% |
| Delirium |
4.2% |
| Drug Interaction |
4.2% |
| Dysphonia |
4.2% |
| Faecaloma |
4.2% |
| Hallucination |
4.2% |
| Inadequate Analgesia |
4.2% |
| Loss Of Consciousness |
4.2% |
| Obsessive Thoughts |
4.2% |
| Overdose |
4.2% |
| Rash Pruritic |
4.2% |
| Renal Cancer |
4.2% |
| Renal Failure Chronic |
4.2% |
| Renal Impairment |
4.2% |
| Somnolence |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
44.7% |
| Pain |
13.9% |
| Prostate Cancer Metastatic |
8.7% |
| Drug Use For Unknown Indication |
6.3% |
| Anaemia |
4.3% |
| Atrial Fibrillation |
2.9% |
| Osteoporosis |
2.4% |
| Back Pain |
1.9% |
| Cardiac Fibrillation |
1.9% |
| Gastrointestinal Disorder Therapy |
1.4% |
| Hormone Therapy |
1.4% |
| Mineral Supplementation |
1.4% |
| Neuralgia |
1.4% |
| Sciatica |
1.4% |
| Arthritis |
1.0% |
| Back Injury |
1.0% |
| Hypertension |
1.0% |
| Macular Degeneration |
1.0% |
| Muscle Spasms |
1.0% |
| Palpitations |
1.0% |
|
| Urinary Tract Infection |
18.2% |
| Memory Impairment |
9.1% |
| Renal Cancer |
9.1% |
| Viral Upper Respiratory Tract Infection |
9.1% |
| Somnolence |
6.1% |
| Weight Increased |
6.1% |
| Constipation |
3.0% |
| Decreased Appetite |
3.0% |
| Delirium |
3.0% |
| Haematemesis |
3.0% |
| Hip Fracture |
3.0% |
| Hypersensitivity |
3.0% |
| Hypotension |
3.0% |
| Maternal Exposure Timing Unspecified |
3.0% |
| Neutropenic Infection |
3.0% |
| Overdose |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Chronic |
3.0% |
| Renal Impairment |
3.0% |
| Therapeutic Agent Toxicity |
3.0% |
|
| Concomitant |
| Pain |
14.4% |
| Rheumatoid Arthritis |
10.7% |
| Drug Use For Unknown Indication |
7.3% |
| Product Used For Unknown Indication |
7.0% |
| Atrial Fibrillation |
6.8% |
| Spinal Osteoarthritis |
6.8% |
| Hypertension |
5.7% |
| Osteoporosis |
5.2% |
| Extradural Abscess |
4.7% |
| Procedural Pain |
4.7% |
| Insomnia |
4.2% |
| Anxiety Disorder |
3.1% |
| Mental Disorder |
3.1% |
| Hypothyroidism |
2.9% |
| Cerebrovascular Accident Prophylaxis |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Back Pain |
2.1% |
| Constipation |
2.1% |
| Diabetes Mellitus |
2.1% |
| Medical Diet |
2.1% |
|
| Vomiting |
11.3% |
| White Blood Cell Count Decreased |
11.3% |
| Glomerular Filtration Rate Decreased |
9.7% |
| Aphasia |
6.5% |
| Pancreatitis |
4.8% |
| Speech Disorder |
4.8% |
| Suicidal Ideation |
4.8% |
| Urinary Retention |
4.8% |
| Urinary Tract Infection |
4.8% |
| Visual Impairment |
4.8% |
| Cardiac Failure |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Coma |
3.2% |
| Hip Fracture |
3.2% |
| Nausea |
3.2% |
| Pneumonia |
3.2% |
| Prothrombin Level Decreased |
3.2% |
| Renal Failure Acute |
3.2% |
| Rosacea |
3.2% |
| Skin Ulcer |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
|
